One of the important signals during NLRP3 initiation and activation is diabetes-induced hyperglycemia and hyperlipidemia, which can promote ROS overexpression to activate the NF-κB signaling pathway and thus the transcription of NLRP3, pro-IL-1β, and pro-IL-18. The gene discussed is NLRP3; the disease is hyperlipidemia.